Quick Answer
Caribou Biosciences, Inc. reported Net Income of -$148.12 million for fiscal year 2025.
Caribou Biosciences, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$148.12M | +0.7% |
| 2024 | -$149.10M | -46.1% |
| 2023 | -$102.07M | -2.7% |
| 2022 | -$99.42M | -48.6% |
| 2021 | -$66.92M | -95.1% |
| 2020 | -$34.31M | -46.4% |
| 2019 | -$23.43M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$27.55M | +20.6% | +49.1% |
| June 30, 2025 | -$54.10M | -43.5% | -35.3% |
| March 31, 2025 | -$39.99M | +3.0% | -15.3% |
| September 30, 2024 | -$34.68M | -246.8% | +8.0% |
| June 30, 2024 | -$37.70M | -27.7% | +8.6% |
| March 31, 2024 | -$41.23M | -47.0% | -312.3% |
| September 30, 2023 | -$10.00M | +62.5% | +66.1% |
| June 30, 2023 | -$29.52M | -10.6% | -5.3% |
- Caribou Biosciences, Inc. showed an increase of +0.7% in Net Income compared to the prior fiscal year.
- Over the 2019–2025 period, Caribou Biosciences, Inc.’s net income has declined by 532.2% (from -$23.43 million to -$148.12 million).
- The most recent figure is from Caribou Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: